A Study to Evaluate Single Subcutaneous Doses of NXT007 Among Injection Sites Abdomen, Upper Arm, and Thigh in Healthy Male Participants
Clinical trial NCT06189508 · COMPLETED
Trial details
- NCT number
- NCT06189508
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-14
- Primary completion
- 2024-12-22
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.